Jack Nathan Medical : Investor Presentation

INVESTOR PRESENTATION

JNH: TSXV | JNHMF: OTCQB

November 2021

"A Revolution in Healthcare"

FORWARD LOOKING INFORMATION

Neither TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this presentation.

Except for the historical statements contained herein, this presentation may present "forward-looking statements" within the meaning of Canadian securities legislation that involve inherent risks and uncertainties. Forward-looking statements include, but are not limited to, future developments; and the business and operations of the issuer. Generally, these forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "proposed" "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved".

Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Jack Nathan Medical Corp. ("JNH", "Jack Nathan" or the "Company") to be materially different from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; delay or failure to receive board, shareholder or regulatory approvals; and the results of continued development, marketing and sales as well as those factors disclosed in Jack Nathan Medical Corp.'s publicly filed documents. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Although the management and officers of Jack Nathan believe that the expectations reflected in such forward-looking statements are based upon reasonable assumptions and have attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Jack Nathan does not undertake to update any forward-looking statements that are incorporated by reference herein, except in accordance with applicable securities laws.

COVID-19

Since December 31, 2019, the COVID-19 pandemic has caused a widespread health crisis that has affected economies and financial markets around the world resulting in an economic downturn. In response to the outbreak, governmental authorities in Canada and internationally have introduced various recommendations and measures to try to limit the pandemic, including travel restrictions, border closures, non-essential business closures, quarantines, self-isolations,shelters-in-place and social distancing. The COVID-19 outbreak and the response of governmental authorities to try to limit it are having a significant impact on the private sector and individuals, including unprecedented business, employment and economic disruptions. The continued spread of COVID-19 nationally and globally could have an adverse impact on the Company's business, operations and financial results, as well as a deterioration of general economic conditions including a possible national or global recession. Due to the speed with which the COVID-19 situation is

developing and the uncertainty of its magnitude, outcome and duration, it is not possible to estimate its impact on the Company's	2
business, operations or financial results, including the Company's ability to secure financing; however, the impact could be material.

TODAY'S AGENDA

Presentation Outline

Speakers

Dr. Glenn Copeland	David Berman
Chief Executive Officer &	Chief Financial Officer
Chief Medical Officer

1. Key Highlights
2. Healthcare Market
3. About Jack Nathan Health
4. Alliance with Walmart
5. JNH Clinic Expansion
6. Growth Strategy
7. Financial Results
8. FY2022 Priorities
9. Why Invest in JNH

3

KEY HIGHLIGHTS

1. Overstressed Healthcare Market in Canada and Mexico

Millions of Canadians and Mexicans do not have regular access to a family doctor and other healthcare professionals

2.

3.

Strong Partnership with Walmart

Jack Nathan Health clinics are located inside Walmart® stores

Rapid Expansion to Broad Clinic Network in Canada and Mexico

Over 190 clinics across Canada and Mexico with 3 new clinics to open in Canada and plans to reach up to 203 clinics in Mexico next year

4. Acquisition Strategy and Roll-Out Plans

Converting licensed clinics to corporate-owned clinics to significantly drive top and bottom-line performance

5. Technology Investments and New Ancillary Services

Writi acquisition growing; investing to improve partner/patient engagement as well as offer allied services that are privately billed within new clinic formats

4

CANADIAN AND MEXICAN HEALTHCARE LANDSCAPE

Healthcare spending in Canada to reach $308 billion in 2021

4.6 million Canadians don't have regular access to a family

doctor

The vast majority of

Mexicans do not have

access to a family doctor and other healthcare providers